Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWitan Regulatory News (WTAN)

Share Price Information for Witan (WTAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 256.00
Bid: 255.00
Ask: 255.50
Change: 1.50 (0.59%)
Spread: 0.50 (0.196%)
Open: 252.00
High: 256.00
Low: 252.00
Prev. Close: 254.50
WTAN Live PriceLast checked at -
Witan is an Investment Trust

To achieve an investment total return exceeding that of the benchmark of the Company over the longer term, together with growth in the dividend ahead of inflation through active investment in global equities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Unbound Group plc

19 May 2023 14:57

RNS Number : 0803A
Witan Investment Trust PLC
19 May 2023
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Witan Investment Trust plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Unbound Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

19 May 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary shares of 1p each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

10,305,996

15.82

NIL

 

(2) Cash-settled derivatives:

 

NIL

 

NIL

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

NIL

 

NIL

 

 

TOTAL:

 

10,305,996

 

15.82

 

NIL

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

 

19 May 2023

Contact name:

 

Eleanor Cranmer

Frostrow Capital LLP

Company Secretary

 

Telephone number:

 

020 3008 4613

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETXKLFFXELEBBE
Date   Source Headline
1st May 20245:45 pmRNSDividend Declaration
1st May 20245:31 pmRNSTransaction in Own Shares
1st May 20245:24 pmRNSShare buyback authority
1st May 20245:12 pmRNSResult of AGM
1st May 20242:06 pmRNSNet Asset Value(s)
1st May 202410:08 amRNSTotal Voting Rights
30th Apr 20245:14 pmRNSTransaction in Own Shares
30th Apr 202412:37 pmRNSNet Asset Value(s)
29th Apr 20245:24 pmRNSTransaction in Own Shares
29th Apr 202412:57 pmRNSNet Asset Value(s)
26th Apr 20245:09 pmRNSTransaction in Own Shares
26th Apr 20242:15 pmRNSNet Asset Value(s)
25th Apr 20245:23 pmRNSTransaction in Own Shares
25th Apr 20242:27 pmRNSNet Asset Value(s)
25th Apr 20247:00 amRNSKepler Trust Intelligence: New Research
24th Apr 20245:18 pmRNSTransaction in Own Shares
24th Apr 20241:27 pmRNSNet Asset Value(s)
23rd Apr 20245:06 pmRNSTransaction in Own Shares
23rd Apr 202412:51 pmRNSNet Asset Value(s)
22nd Apr 20245:02 pmRNSTransaction in Own Shares
22nd Apr 202412:30 pmRNSNet Asset Value(s)
19th Apr 20245:20 pmRNSTransaction in Own Shares
19th Apr 202412:51 pmRNSNet Asset Value(s)
18th Apr 20245:19 pmRNSTransaction in Own Shares
18th Apr 202412:46 pmRNSNet Asset Value(s)
17th Apr 20245:08 pmRNSTransaction in Own Shares
17th Apr 20242:34 pmRNSPortfolio Listing as at 31 March 2024
17th Apr 20242:32 pmRNSMonthly Factsheet as at 31 March 2024
17th Apr 202411:27 amRNSNet Asset Value(s)
16th Apr 20245:07 pmRNSTransaction in Own Shares
16th Apr 202412:28 pmRNSNet Asset Value(s)
15th Apr 20245:24 pmRNSTransaction in Own Shares
15th Apr 20241:49 pmRNSNet Asset Value(s)
15th Apr 20247:00 amRNSNotice of AGM: correction of Form of Proxy
12th Apr 20245:21 pmRNSTransaction in Own Shares
12th Apr 202412:59 pmRNSNet Asset Value(s)
11th Apr 20245:21 pmRNSTransaction in Own Shares
11th Apr 20242:32 pmRNSNet Asset Value(s)
10th Apr 20245:06 pmRNSTransaction in Own Shares
10th Apr 202412:46 pmRNSNet Asset Value(s)
9th Apr 20245:10 pmRNSTransaction in Own Shares
9th Apr 20242:54 pmRNSNet Asset Value(s)
8th Apr 20245:21 pmRNSTransaction in Own Shares
8th Apr 202412:21 pmRNSNet Asset Value(s)
5th Apr 202412:41 pmRNSNet Asset Value(s)
4th Apr 20245:03 pmRNSTransaction in Own Shares
4th Apr 20242:53 pmRNSNet Asset Value(s)
3rd Apr 20245:17 pmRNSTransaction in Own Shares
3rd Apr 202412:28 pmRNSNet Asset Value(s)
2nd Apr 20244:59 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.